Benzinga | Aug 5, 2020 07:31AM EDT

Evogene Q1 GAAP EPS $(0.24) Down From $(0.15) YoY, Sales $75.00K Miss $1.90M Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.24) per share. This is a 60 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $75.00 thousand which missed the analyst consensus estimate of $1.90 million by 96.05 percent. This is a 78.45 percent decrease over sales of $348.00 thousand the same period last year.